Molecular markers as an indicator in the malignant potential of oral lichen planus: A systematic review

Document Type: Review Article(s)

Authors

1 Associate Professor, Department of Oral Medicine, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

2 Dentist, Private Practice, Kerman, Iran

3 Associate Professor, Kerman Social Determinants on Oral Health Research Center, Kerman University of Medical Sciences, Kerman, Iran

Abstract

BACKGROUND AND AIM: Oral lichen planus (OLP) is a chronic, autoimmune, inflammatory disease. The progression of OLP to oral squamous cell carcinoma (OSCC) has generated a longstanding controversy about the details of this malignant transformation potential. This study aimed to do a systematic review on the molecular markers related to the malignant transformation of OLP.METHODS: We searched the databases PubMed, Google Scholar, Science Direct, Scopus, Cochrane and Thomson Reuters Web of Science (1990-2015) with the MeSH key words of: (“oral lichenoid reaction”, “oral lichenoid lesion”, “oral lichenoid eruption”, “oral lichen planus” “lichen planus”, “lichenoid”) AND (“malignant transformation”, “premalignant character”, “cancerization”, “pre-neoplasm”, “squamous cell carcinoma”). The reviewers screened the identified publications in three steps according to title, abstract and full text, extracted all the investigated markers in screened articles and finally classified the markers according to the frequency. Extracted data were saved in Excel software.RESULTS: Out of 570 articles, 66 were finally enrolled in the study. The most frequent evaluated markers were p53, cyclooxygenase-2 (COX-2), Ki67, B-cell lymphoma-2 (Bcl-2), Bax, p21, and caspase-3.CONCLUSION: The present study concluded that there were some documented evidences for association between malignant transformation of OLP and seven molecular markers (p53, COX-2, Ki67, Bcl-2, Bax, p21, and caspase-3).

Keywords


  1. Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases 2014; 2(12): 866-72.
  2. Thongprasom K, Youngnak-Piboonratanakit P, Pongsiriwet S, Laothumthut T, Kanjanabud P, Rutchakitprakarn L. A multicenter study of oral lichen planus in Thai patients. J Investig Clin Dent 2010; 1(1): 29-36.
  3. Werneck JT, Costa TO, Stibich CA, Leite CA, Dias EP, Silva Junior A. Oral lichen planus: Study of 21 cases. An Bras Dermatol 2015; 90(3): 321-6.
  4. Gumru B. A retrospective study of 370 patients with oral lichen planus in Turkey. Med Oral Patol Oral Cir Bucal 2013; 18(3): e427-e432.
  5. Torrente-Castells E, Figueiredo R, Berini-Aytes L, Gay-Escoda C. Clinical features of oral lichen planus. A retrospective study of 65 cases. Med Oral Patol Oral Cir Bucal 2010; 15(5): e685-e690.
  6. Bombeccari GP, Guzzi G, Tettamanti M, Gianni AB, Baj A, Pallotti F, et al. Oral lichen planus and malignant transformation: a longitudinal cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112(3): 328-34.
  7. Ismail SB, Kumar SK, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007; 49(2): 89-106.
  8. Giacomelli L, Oluwadara O, Chiappe G, Barone A, Chiappelli F, Covani U. Relationship between human oral lichen planus and oral squamous cell carcinoma at a genomic level: a datamining study. Bioinformation 2009; 4(6): 258-62.
  9. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014; 145(1): 45-56.
  10. Navabi N, Aramon M, Mirzazadeh A. Does the presence of the Helicobacter pylori in the dental plaque associate with its gastric infection? A meta-analysis and systematic review. Dent Res J (Isfahan) 2011; 8(4): 178-82.
  11. Ataei Z, Navabi N, Mohammadi H, Habib-Agahi R. Systematic review and meta-analysis of diagnostic value of epicutaneous patch testing in patients with oral lichenoid lesions. J Oral Health Oral Epidemiol 2015; 4(1): 1-9.
  12. Abdel Hay RM, Fawzy MM, Metwally D, Kadry D, Ezzat M, Rashwan W, et al. DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case-control study. J Eur Acad Dermatol Venereol 2012; 26(9): 1122-6.
  13. Acay RR, Felizzola CR, de Araujo N, de Sousa SO. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol 2006; 42(5): 475-80.
  14. Agha-Hosseini F, Mirzaii-Dizgah I. p53 as a neoplastic biomarker in patients with erosive and plaque like forms of oral lichen planus. J Contemp Dent Pract 2013; 14(1): 1-3.
  15. Arreaza A, Rivera H, Correnti M. p53 expression in oral lichenoid lesions and oral lichen planus. Gen Dent 2015; 63(1): 69-72.
  16. Arreaza AJ, Rivera H, Correnti M. Expression of COX-2 and bcl-2 in oral lichen planus lesions and lichenoid reactions. Ecancermedicalscience 2014; 8: 411.
  17. Bascones C, Gonzalez-Moles MA, Esparza G, Bravo M, Acevedo A, Gil-Montoya JA, et al. Apoptosis and cell cycle arrest in oral lichen planus Hypothesis on their possible influence on its malignant transformation. Arch Oral Biol 2005; 50(10): 873-81.
  18. Bascones-Ilundain C, Gonzalez-Moles MA, Campo-Trapero J, Gil-Montoya JA, Esparza-Gomez GC, Cano-Sanchez J, et al. No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus. J Eur Acad Dermatol Venereol 2008; 22(2): 204-12.
  19. Bascones-Ilundain C, Gonzalez-Moles MA, Esparza-Gomez G, Gil-Montoya JA, Bascones-Martinez A. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions. Anticancer Res 2006; 26(1A): 357-62.
  20. Battino M, Greabu M, Totan A, Bullon P, Bucur A, Tovaru S, et al. Oxidative stress markers in oral lichen planus. Biofactors 2008; 33(4): 301-10.
  21. Bediaga NG, Marichalar-Mendia X, Aguirre-Urizar JM, Calvo B, Echebarria-Goicouria MA, de Pancorbo MM, et al. Global DNA methylation: uncommon event in oral lichenoid disease. Oral Dis 2014; 20(8): 821-6.
  22. Chen Y, Zhang W, Geng N, Tian K, Jack Windsor L. MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head Neck 2008; 30(9): 1237-45.
  23. Cheng YS, Jordan L, Rees T, Chen HS, Oxford L, Brinkmann O, et al. Levels of potential oral cancer salivary mRNA biomarkers in oral cancer patients in remission and oral lichen planus patients. Clin Oral Investig 2014; 18(3): 985-93.
  24. Cheng YS, Rees T, Jordan L, Oxford L, O'Brien J, Chen HS, et al. Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol 2011; 47(12): 1122-6.
  25. Chitturi RT, Nirmal RM, Sunil PM, Devy AS, Reddy BV. Evaluation of ploidy status using DNA-image cytometry of exfoliated mucosal cells in oral lichen planus. J Cytol 2014; 31(3): 131-5.
  26. Cortes-Ramirez DA, Rodriguez-Tojo MJ, Gainza-Cirauqui ML, Martinez-Conde R, Aguirre-Urizar JM. Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110(6): 738-43.
  27. Czerninski R, Basile J, Kartin-Gabay T, Laviv A, Barak V. Levels of the cytokines IL-6, IL-8, sIL-2R, IL-1B and the tumor markers SCC, TPS, and VEGF IN patients with oral lichen planus and premalignancy vs oral squamous cell carcinoma. Oral Oncol 2013; 49(Supplement 1): S97.
  28. Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L. Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol 2012; 26(11): 1415-9.
  29. de Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma. Ann Diagn Pathol 2009; 13(5): 308-12.
  30. Fan Y, Zhan Z, Peng T, Song XL, Feng ZQ. The expression of apoptosis-associated proteins Bcl-2, Bax in oral leukoplakia and lichen planus. Shanghai Kou Qiang Yi Xue 2004; 13(6): 497-501.
  31. Georgakopoulou EA, Troupis TG, Troupis G, Gorgoulis VG. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature. J BUON 2011; 16(4): 613-6.
  32. Gonzalez Moles MA, Esteban F, Ruiz-Avila I, Gil Montoya JA, Brener S, Bascones-Martinez A, et al. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus. Oral Dis 2009; 15(2): 162-9.
  33. Gonzalez-Moles MA, Bascones-Ilundain C, Gil Montoya JA, Ruiz-Avila I, Delgado-Rodriguez M, Bascones-Martinez A. Cell cycle regulating mechanisms in oral lichen planus: Molecular bases in epithelium predisposed to malignant transformation. Arch Oral Biol 2006; 51(12): 1093-103.
  34. Hadzi-Mihailovic M, Raybaud H, Monteil R, Cakic S, Djuric M, Jankovic L. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. J BUON 2010; 15(2): 362-8.
  35. Hadzi-Mihailovic M, Raybaud H, Monteil R, Jankovic L. Expression of Fas/FasL in patients with oral lichen planus. J BUON 2009; 14(3): 487-93.
  36. Hakkinen L, Kainulainen T, Salo T, Grenman R, Larjava H. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999; 5(3): 210-7.
  37. Kim J, Yook JI, Lee EH, Ryu MH, Yoon JH, Hong JC, et al. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics. J Oral Pathol Med 2001; 30(2): 65-72.
  38. Lee JJ, Kuo MY, Cheng SJ, Chiang CP, Jeng JH, Chang HH, et al. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99(4): 471-8.
  39. Leyva-Huerta ER, Ledesma-Montes C, Rojo-Botello RE, Vega-Memije E. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2012; 17(5): e745-e750.
  40. Li TJ, Cui J. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. Asian Pac J Trop Med 2013; 6(8): 640-3.
  41. Li N, Hu Q, Jiang C, Guo F, Munnee K, Jian X, et al. Cys-X-Cys ligand 9 might be an immunological factor in the pathogenesis of oral submucous fibrosis and its concomitant oral lichenoid lesion. Clin Oral Investig 2013; 17(4): 1251-8.
  42. Lysitsa S, Samson J, Gerber-Wicht C, Lang U, Lombardi T. COX-2 expression in oral lichen planus. Dermatology 2008; 217(2): 150-5.
  43. Ma L, Wang H, Yao H, Zhu L, Liu W, Zhou Z. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma. Ann Diagn Pathol 2013; 17(4): 327-30.
  44. Maraki D, Yalcinkaya S, Pomjanski N, Megahed M, Boecking A, Becker J. Cytologic and DNA-cytometric examination of oral lesions in lichen planus. J Oral Pathol Med 2006; 35(4): 227-32.
  45. Mattila R, Alanen K, Syrjanen S. DNA content as a prognostic marker of oral lichen planus with a risk of cancer development. Anal Quant Cytol Histol 2004; 26(5): 278-84.
  46. Mattila R, Alanen K, Syrjanen S. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions. Arch Dermatol Res 2007; 298(8): 381-8.
  47. Mattila R, Alanen K, Syrjanen S. Desmocollin expression in oral atrophic lichen planus correlates with clinical behavior and DNA content. J Cutan Pathol 2008; 35(9): 832-8.
  48. Balachandran C, Vasanth V. Lichen planus in association with malignancy-a new paraneoplastic marker - report of two cases. Journal of Pakistan Association of Dermatologists 2010; 20(1): 39-41.
  49. Montebugnoli L, Venturi M, Gissi DB, Leonardi E, Farnedi A, Foschini MP. Immunohistochemical expression of p16(INK4A) protein in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011; 112(2): 222-7.
  50. Mortazavi N. Role of oxidative stress in malignant transformation of oral lichen planus. Oral Oncol 2013; 49(12): e41-e42.
  51. Nafarzadeh S, Ejtehadi S, Amini SP, Fereidooni M, Bijani A. Comparative study of expression of smad3 in oral lichen planus and normal oral mucosa. Int J Mol Cell Med 2013; 2(4): 194-8.
  52. Nafarzadeh S, Jafari S, Bijani A. Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Int J Mol Cell Med 2013; 2(3): 136-42.
  53. Neppelberg E, Johannessen AC. DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus. Eur Arch Otorhinolaryngol 2007; 264(10): 1223-30.
  54. Nylander E, Ebrahimi M, Wahlin YB, Boldrup L, Nylander K. Changes in miRNA expression in sera and correlation to duration of disease in patients with multifocal mucosal lichen planus. J Oral Pathol Med 2012; 41(1): 86-9.
  55. Ogmundsdottir HM, Hilmarsdottir H, Astvaldsdottir A, Johannsson JH, Holbrook WP. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Eur J Oral Sci 2002; 110(3): 192-8.
  56. Oliveira Alves M, Balducci I, Rodarte Carvalho Y, Cabral L, Nunes F, Almeida J. Evaluation of the expression of p53, MDM2, and SUMO-1 in oral lichen planus. Oral Dis 2013; 19(8): 775-80.
  57. Pigatti FM, Taveira LA, Soares CT. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia. Int J Dermatol 2015; 54(2): 150-5.
  58. Pimenta FJ, Pinheiro MD, Gomez RS. Expression of hMSH2 protein of the human DNA mismatch repair system in oral lichen planus. Int J Med Sci 2004; 1(3): 146-51.
  59. Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy. J Oral Pathol Med 2011; 40(4): 294-9.
  60. Prodromidis G, Nikitakis NG, Sklavounou A. Immunohistochemical analysis of the activation status of the Akt/mTOR/pS6 signaling pathway in oral lichen planus. Int J Dent 2013; 2013: 743456.
  61. Pusiol T, Zorzi MG, Morichetti D, Speziali L. Pseudoepitheliomatous hyperplasia arising from hypertrophic lichen planus mimicking squamous cell carcinoma: limited value of immunohistochemistry. Acta Dermatovenerol Croat 2012; 20(2): 112-4.
  62. Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 2005; 44(2): 77-82.
  63. Rivarola de Gutierrez E, Innocenti AC, Cippitelli MJ, Salomon S, Vargas-Roig LM. Determination of cytokeratins 1, 13 and 14 in oral lichen planus. Med Oral Patol Oral Cir Bucal 2014; 19(4): e359-e365.
  64. Rode M, Flezar MS, Kogoj-Rode M, Us-Krasovec M. Image cytometric evaluation of nuclear texture features and DNA content of the reticular form of oral lichen planus. Anal Quant Cytol Histol 2006; 28(5): 262-8.
  65. Safadi RA, Al Jaber SZ, Hammad HM, Hamasha AA. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study. Arch Oral Biol 2010; 55(6): 454-61.
  66. Segura S, Rozas-Munoz E, Toll A, Martin-Ezquerra G, Masferrer E, Espinet B, et al. Evaluation of MYC status in oral lichen planus in patients with progression to oral squamous cell carcinoma. Br J Dermatol 2013; 169(1): 106-14.
  67. Shi P, Liu W, Zhou ZT, He QB, Jiang WW. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiol Biomarkers Prev 2010; 19(3): 844-9.
  68. Shi W, Feng Z, Zhao C, Lv G, Shan X, Hua H, et al. OP002: Identification of seven miRNAs as potential biomarkers for oral lichen planus and oral squamous cell carcinoma: A pilot study. Oral Oncol 2013; 49(Supplement 1): S4-S5.
  69. Sousa FA, Paradella TC, Carvalho YR, Rosa LE. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia. J Oral Sci 2009; 51(1): 117-21.
  70. Sun L, Feng J, Ma L, Liu W, Zhou Z. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma. Ann Diagn Pathol 2013; 17(6): 486-9.
  71. Tekkesin MS, Sinanoglu A, Aksakalli N. Assessment of p53 and Bcl-2 Protein Expressions in Oral Lichen Planus and Oral Squamous Cell Carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119(3): e191.
  72. Thongprasom K, Mutirangura A, Cheerat S. Telomerase activity in oral lichen planus. J Oral Pathol Med 1998; 27(8): 395-8.
  73. Valente G, Pagano M, Carrozzo M, Carbone M, Bobba V, Palestro G, et al. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med 2001; 30(3): 135-40.
  74. Xu Z, Shen Z, Shi L, Sun H, Liu W, Zhou Z. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus. Ann Diagn Pathol 2013; 17(5): 408-11.
  75. Zargaran M, Jamshidi S, Eshghyar N, Moghimbeigi A. Suitability/unsuitability of cell proliferation as an indicator of malignant potential in oral lichen planus: an immunohistochemical study. Asian Pac J Cancer Prev 2013; 14(11): 6979-83.
  76. Zhang L, Michelsen C, Cheng X, Zeng T, Priddy R, Rosin MP. Molecular analysis of oral lichen planus. A premalignant lesion? Am J Pathol 1997; 151(2): 323-7.
  77. Zhao M, Fu XL, Lv H. The expression of EGFR in oral lichen planus, squamous cell papilloma and squamous cell carcinoma. Shanghai Kou Qiang Yi Xue 2012; 21(6): 673-6.